GENDRON PAUL ANDREW 4
4 · InfuSystem Holdings, Inc · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
InfuSystem (INFU) Director Paul Gendron Buys 5,000 Shares
What Happened
Paul Andrew Gendron, a director of InfuSystem Holdings, purchased 5,000 shares of INFU in open-market transactions on May 8, 2026. The reported weighted-average price was $8.88 per share, for a total reported outlay of approximately $44,400. This is a purchase (insider buy), which many investors view as a clearexpression of alignment with the company, though it does not prove future performance.
Key Details
- Transaction date: 2026-05-08; Filing date: 2026-05-12 (filed four days after the trade).
- Transaction type/code: Open market purchase (P). Reported weighted-average price: $8.88; total reported value: $44,400.
- Shares purchased: 5,000. Shares owned after transaction: not specified in the filing.
- Footnote: The $8.88 price is a weighted average because the shares were acquired in multiple transactions; the reporting person will provide per-fill details upon request (Footnote F1).
- No indication in the filing of a 10b5-1 plan, gift, option exercise, or tax-withholding event.
Context
Director purchases are often watched by retail investors as a sign of confidence, but this is a relatively modest $44k buy and should be weighed with other data. The footnote confirms multiple executions at different prices; you can request full per-transaction pricing from the company or the SEC staff if you need exact fills.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-05-08$8.88/sh+5,000$44,400→ 70,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting person undertakes to provide to the Issuer, and security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.